文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

细针抽吸洗脱沉淀标本:甲状腺结节基因突变检测的一种可接受的补充方法。

Fine-needle Aspiration Washout Precipitation Specimens: An Acceptable Supplement to Genetic Mutation Detection of Thyroid Nodules.

机构信息

Department of Pathology, 144991The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

出版信息

Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211057982. doi: 10.1177/15330338211057982.


DOI:10.1177/15330338211057982
PMID:34806478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8606728/
Abstract

Thyroid nodules are common in adults, but only some of them are malignant. Ultrasound-guided fine-needle aspiration (FNA) is widely applied as a reliable and minimally invasive technique for evaluating thyroid nodules. However, the scarcity of FNA biopsy specimens poses a challenge to molecular diagnosis. This study aimed to evaluate the feasibility of FNA washout precipitation specimens as an effective supplement to the thyroid genetic test. A total of 115 patients with thyroid nodules were enrolled in our study. The V600E mutation status was detected in all FNA washout precipitation specimens and biopsy formalin-fixed paraffin-embedded (FFPE) specimens using an amplification refractory mutation system PCR (ARMS-PCR). All patients underwent cytological diagnoses; 79 patients also underwent surgery for histopathological analysis. All the 115 samples were successfully analyzed using both FNA washout precipitation and biopsy FFPE specimens. The results showed that the V600E status detected in 96 FNA washout precipitation specimens were consistent with that in FNA biopsy FFPE specimens, including 41 V600E positive and 55 V600E negative, achieving a concordance rate of 84.4% (kappa  =  0.689). Furthermore, the V600E mutation status using FNA washout precipitation specimens provided a 100.0% positive predictive value for diagnosing papillary thyroid carcinoma in patients with The Bethesda system for reporting thyroid cytopathology (TBSRTC) V. Besides, the V600E mutation status was positive in 90.9% (10/11) FNA washout precipitation specimens from patients with capsule invasion, achieving a higher overall sensitivity of 100.0%, compared with 57.1% of FNA washout precipitation specimens from patients without capsule invasion. These results suggested that FNA washout precipitation specimens might be a valuable supplementary sample type for detecting the V600E mutation in patients with thyroid nodules, especially with thyroid capsule invasion.

摘要

甲状腺结节在成年人中很常见,但并非所有结节都是恶性的。超声引导下的细针抽吸(FNA)是一种广泛应用的可靠、微创技术,用于评估甲状腺结节。然而,FNA 活检标本的稀缺性给分子诊断带来了挑战。本研究旨在评估 FNA 洗脱沉淀标本作为甲状腺基因检测有效补充的可行性。

我们的研究共纳入了 115 例甲状腺结节患者。采用扩增受阻突变系统 PCR(ARMS-PCR)检测所有 FNA 洗脱沉淀标本和活检福尔马林固定石蜡包埋(FFPE)标本中的 V600E 突变状态。所有患者均进行细胞学诊断;79 例患者还接受了手术进行组织病理学分析。所有 115 例标本均成功地使用 FNA 洗脱沉淀和活检 FFPE 标本进行了分析。结果显示,96 例 FNA 洗脱沉淀标本中的 V600E 状态与 FNA 活检 FFPE 标本一致,包括 41 例 V600E 阳性和 55 例 V600E 阴性,一致性率为 84.4%(kappa 值=0.689)。此外,FNA 洗脱沉淀标本 V600E 突变状态对诊断具有 Bethesda 甲状腺细胞病理学报告系统(TBSRTC)V 级的患者的甲状腺乳头状癌具有 100.0%的阳性预测值。此外,9 例(10/11)甲状腺包膜侵犯患者的 FNA 洗脱沉淀标本 V600E 突变状态为阳性,总体敏感性为 100.0%,高于无甲状腺包膜侵犯患者的 FNA 洗脱沉淀标本(57.1%)。

这些结果表明,FNA 洗脱沉淀标本可能是一种有价值的补充标本类型,可用于检测甲状腺结节患者的 V600E 突变,特别是甲状腺包膜侵犯的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710d/8606728/03ac5c5cb6ac/10.1177_15330338211057982-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710d/8606728/03ac5c5cb6ac/10.1177_15330338211057982-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/710d/8606728/03ac5c5cb6ac/10.1177_15330338211057982-fig1.jpg

相似文献

[1]
Fine-needle Aspiration Washout Precipitation Specimens: An Acceptable Supplement to Genetic Mutation Detection of Thyroid Nodules.

Technol Cancer Res Treat. 2021

[2]
BRAF mutation test on fine-needle aspiration specimens of thyroid nodules: Clinical correlations for 4600 patients.

Cancer Med. 2022-1

[3]
Development of a Molecular Assay for Detection and Quantification of the BRAF Variation in Residual Tissue From Thyroid Nodule Fine-Needle Aspiration Biopsy Specimens.

JAMA Netw Open. 2021-10-1

[4]
Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens.

Acta Cytol. 2011

[5]
Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.

Diagn Cytopathol. 2015-10

[6]
BRAF V600E mutation and the Bethesda System for Reporting Thyroid Cytopathology of fine-needle aspiration biopsy for distinguishing benign from malignant thyroid nodules.

Medicine (Baltimore). 2021-9-17

[7]
Diagnostic Value and Challenges of BRAF V600E Molecular Testing and Thyroid Fine-Needle Aspiration Cytology: A Retrospective Study from a Tertiary Institution in Southern Hunan Province, China.

Acta Cytol. 2023

[8]
Comparison of the Clinical Validity of Droplet Digital PCR to ARMS-PCR for BRAF V600E Mutation Detection in Thyroid Nodules.

J Clin Lab Anal. 2020-11

[9]
The Combined Use of Fine-Needle Aspiration (FNA) and BRAF V600E Gene Testing: Can it Increase the Definitive Diagnosis Rate of Nodules Categorized as Bethesda III for Papillary Thyroid Carcinoma?

Am Surg. 2024-12

[10]
BRAF mutation analysis by ARMS-PCR refines thyroid nodule management.

Clin Endocrinol (Oxf). 2019-12

引用本文的文献

[1]
BRAF Detection in FNAC Combined with Semi-Quantitative Tc-MIBI Technique and AI Model, an Economic and Efficient Predicting Tool for Malignancy in Thyroid Nodules.

Diagnostics (Basel). 2024-6-30

本文引用的文献

[1]
Real-life use of BRAF-V600E mutation analysis in thyroid nodule fine needle aspiration: consequences on clinical decision-making.

Endocrine. 2021-9

[2]
Thyroid paraganglioma: A diagnostic pitfall in thyroid FNA.

Cancer Cytopathol. 2021-6

[3]
Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples.

Thyroid. 2021-4

[4]
Thyroid Nodules: Advances in Evaluation and Management.

Am Fam Physician. 2020-9-1

[5]
The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC): A report of 2,781 cases in a Chinese population.

Chin J Cancer Res. 2020-4

[6]
Does the Site of Origin of the Microcarcinoma with Respect to the Thyroid Surface Matter? A Multicenter Pathologic and Clinical Study for Risk Stratification.

Cancers (Basel). 2020-1-19

[7]
Diagnostic values of thyroglobulin in lymph node fine-needle aspiration washout: a systematic review and meta-analysis diagnostic values of FNA-Tg.

Endocr J. 2019-11-14

[8]
The Role of Molecular Testing for the Indeterminate Thyroid FNA.

Genes (Basel). 2019-9-23

[9]
BRAF mutation analysis by ARMS-PCR refines thyroid nodule management.

Clin Endocrinol (Oxf). 2019-12

[10]
. TIRADS in predicting papillary thyroid cancers in Bethesda system I, III, and V nodules.

Cancer Biol Med. 2019-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索